Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) and RYTHM (NASDAQ:RYM – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends.
Insider and Institutional Ownership
1.9% of Shionogi & Co., Ltd. Unsponsored ADR shares are owned by institutional investors. Comparatively, 6.0% of RYTHM shares are owned by institutional investors. 3.5% of RYTHM shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings for Shionogi & Co., Ltd. Unsponsored ADR and RYTHM, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Shionogi & Co., Ltd. Unsponsored ADR | 0 | 0 | 0 | 3 | 4.00 |
| RYTHM | 1 | 0 | 0 | 0 | 1.00 |
Volatility and Risk
Shionogi & Co., Ltd. Unsponsored ADR has a beta of 0.1, meaning that its share price is 90% less volatile than the S&P 500. Comparatively, RYTHM has a beta of 9.94, meaning that its share price is 894% more volatile than the S&P 500.
Profitability
This table compares Shionogi & Co., Ltd. Unsponsored ADR and RYTHM’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Shionogi & Co., Ltd. Unsponsored ADR | 37.95% | 14.32% | 10.24% |
| RYTHM | 9.84% | 21.25% | 5.51% |
Earnings & Valuation
This table compares Shionogi & Co., Ltd. Unsponsored ADR and RYTHM”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Shionogi & Co., Ltd. Unsponsored ADR | $3.32 billion | 4.88 | $1.35 billion | $0.90 | 10.58 |
| RYTHM | $70.82 million | 0.49 | -$33.26 million | ($5.27) | -3.05 |
Shionogi & Co., Ltd. Unsponsored ADR has higher revenue and earnings than RYTHM. RYTHM is trading at a lower price-to-earnings ratio than Shionogi & Co., Ltd. Unsponsored ADR, indicating that it is currently the more affordable of the two stocks.
Summary
Shionogi & Co., Ltd. Unsponsored ADR beats RYTHM on 9 of the 13 factors compared between the two stocks.
About Shionogi & Co., Ltd. Unsponsored ADR
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, it has grown from a pharmaceutical wholesaler into a research-focused drugmaker. The company has a particular focus on infectious diseases, including HIV, influenza and COVID-19, and also works in areas such as pain and central nervous system disorders. Its products include Xofluza, an influenza treatment, and ensitrelvir, an oral COVID-19 antiviral marketed in Japan as Xocova.
About RYTHM
Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction.
Receive News & Ratings for Shionogi & Co. Ltd. Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.
